FAT THERAPY IN MALE AND FEMALE PATTERN BALDNESS
Phase 3
Not yet recruiting
- Conditions
- Androgenic alopecia, unspecified,
- Registration Number
- CTRI/2023/09/058150
- Lead Sponsor
- Varsha M
- Brief Summary
Androgenetic alopecia is a type of progressive patterned hair loss. It ischaracterized by stepwise miniaturization of the hair follicle, resulting in alteration in the haircycle dynamics, leading to vellus transformation of the terminal hair. Nanofat transfer is a new and upcoming treatment option for androgenetic alopecia. Theadipose-derived stem cells have self-renewal capacity and also secrete various growth factorsthat have potential for hair growth
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Patient willing to give written informed consent (Annexure 1a, 1b, 1c) 2.
- Patients above 18 years of age and either sex 3.
- Patients with clinically and dermoscopically diagnosed as Androgenetic alopecia 4.
- Patients with BMI < 40kg/m2.
Exclusion Criteria
- Patient not willing to give written informed consent 2.
- Pregnant and lactating women 3.
- Patients with BMI < 18kg/m2 4.
- Patients currently suffering from an active autoimmune disease like SLE, Alopecia aerata 5.
- Patients suffering from any cardiovascular, renal, hematological, pulmonary, gastrointestinal or central nervous system disorders.
- Patients with any bleeding or clotting disorders or on antiplatelet therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Trichoscopic improvement in hair density and hair diameter Baseline, 1 month, 2 months and 6 months
- Secondary Outcome Measures
Name Time Method Improvement in Visual analogue scale Improvement in global photography
Trial Locations
- Locations (1)
Victoria hospital
🇮🇳Bangalore, KARNATAKA, India
Victoria hospital🇮🇳Bangalore, KARNATAKA, IndiaDr Varsha MPrincipal investigator9686284368varshamgowda95@gmail.com